For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of SUPRIYA LIFESCIENCE . For more details, see the SUPRIYA LIFESCIENCE quarterly results and SUPRIYA LIFESCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.7 |
No. of shares | m | 80.48 |
1 Week | % | -9.7 |
1 Month | % | -0.0 |
1 Year | % | 73.8 |
52 week H/L | Rs | 423.5/216.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SUPRIYA LIFESCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 602 | 515 | |
Low | Rs | NA | NA | NA | 377 | 170 | |
Sales per share (Unadj.) | Rs | 160.1 | 180.1 | 48.0 | 58.6 | 50.4 | |
Earnings per share (Unadj.) | Rs | 26.9 | 50.1 | 16.9 | 18.9 | 11.2 | |
Diluted earnings per share | Rs | 4.9 | 9.1 | 15.4 | 18.9 | 11.2 | |
Cash flow per share (Unadj.) | Rs | 30.6 | 54.5 | 17.8 | 20.1 | 12.6 | |
Dividends per share (Unadj.) | Rs | 0 | 2.00 | 0.54 | 0.60 | 0.60 | |
Adj. dividends per share | Rs | 0.00 | 0.36 | 0.49 | 0.60 | 0.60 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0.1 | 0.2 | |
Book value per share (Unadj.) | Rs | 64.1 | 101.9 | 36.7 | 76.5 | 86.9 | |
Adj. book value per share | Rs | 11.7 | 18.5 | 33.4 | 76.5 | 86.9 | |
Shares outstanding (eoy) | m | 14.64 | 14.64 | 73.18 | 80.48 | 80.48 | |
Price / Sales ratio | x | 0 | 0 | 0 | 8.4 | 6.8 | |
Avg P/E ratio | x | 0 | 0 | 0 | 25.9 | 30.7 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 24.3 | 27.1 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 6.4 | 3.9 | |
Dividend payout | % | 0 | 4.0 | 3.2 | 3.2 | 5.4 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 39,384 | 27,581 | |
Total wages/salary | Rs m | 190 | 256 | 328 | 491 | 556 |
SUPRIYA LIFESCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,344 | 2,637 | 3,515 | 4,716 | 4,054 | |
Other income | Rs m | 83 | 111 | 50 | 76 | 100 | |
Total revenues | Rs m | 2,427 | 2,748 | 3,565 | 4,792 | 4,154 | |
Gross profit | Rs m | 644 | 984 | 1,731 | 2,140 | 1,284 | |
Depreciation | Rs m | 54 | 64 | 68 | 101 | 118 | |
Interest | Rs m | 102 | 68 | 41 | 42 | 31 | |
Profit before tax | Rs m | 571 | 962 | 1,673 | 2,072 | 1,235 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 177 | 228 | 437 | 554 | 336 | |
Profit after tax | Rs m | 394 | 734 | 1,236 | 1,518 | 899 | |
Gross profit margin | % | 27.5 | 37.3 | 49.3 | 45.4 | 31.7 | |
Effective tax rate | % | 31.0 | 23.7 | 26.1 | 26.7 | 27.2 | |
Net profit margin | % | 16.8 | 27.8 | 35.2 | 32.2 | 22.2 |
SUPRIYA LIFESCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,327 | 1,980 | 2,655 | 4,975 | 4,649 | |
Current liabilities | Rs m | 1,349 | 1,554 | 1,460 | 997 | 958 | |
Net working cap to sales | % | -1.0 | 16.2 | 34.0 | 84.4 | 91.0 | |
Current ratio | x | 1.0 | 1.3 | 1.8 | 5.0 | 4.9 | |
Inventory Days | Days | 1 | 0 | 1 | 3 | 24 | |
Debtors Days | Days | 93 | 73 | 76 | 89 | 76 | |
Net fixed assets | Rs m | 1,204 | 1,384 | 1,800 | 2,372 | 3,554 | |
Share capital | Rs m | 146 | 146 | 146 | 161 | 161 | |
"Free" reserves | Rs m | 792 | 1,346 | 2,539 | 5,996 | 6,834 | |
Net worth | Rs m | 938 | 1,492 | 2,686 | 6,157 | 6,995 | |
Long term debt | Rs m | 81 | 24 | 0 | 0 | 0 | |
Total assets | Rs m | 2,531 | 3,364 | 4,455 | 7,348 | 8,203 | |
Interest coverage | x | 6.6 | 15.0 | 42.0 | 50.4 | 40.4 | |
Debt to equity ratio | x | 0.1 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.8 | 0.8 | 0.6 | 0.5 | |
Return on assets | % | 19.6 | 23.9 | 28.7 | 21.2 | 11.3 | |
Return on equity | % | 42.0 | 49.2 | 46.0 | 24.7 | 12.8 | |
Return on capital | % | 66.1 | 68.0 | 63.8 | 34.3 | 18.1 | |
Exports to sales | % | 77.8 | 82.6 | 84.9 | 83.2 | 88.8 | |
Imports to sales | % | 29.3 | 28.3 | 17.0 | 20.9 | 23.5 | |
Exports (fob) | Rs m | 1,824 | 2,177 | 2,986 | 3,925 | 3,598 | |
Imports (cif) | Rs m | 686 | 747 | 598 | 985 | 953 | |
Fx inflow | Rs m | 1,824 | 2,177 | 2,986 | 3,925 | 3,598 | |
Fx outflow | Rs m | 695 | 762 | 598 | 985 | 953 | |
Net fx | Rs m | 1,129 | 1,415 | 2,387 | 2,940 | 2,645 |
SUPRIYA LIFESCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 489 | 1,161 | 759 | 488 | 662 | |
From Investments | Rs m | 48 | -245 | -468 | -598 | -1,331 | |
From Financial Activity | Rs m | -499 | -292 | -145 | 1,497 | -34 | |
Net Cashflow | Rs m | 38 | 623 | 146 | 1,386 | -703 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Satish Waman Wagh | COMP SEC: Shweta Shivdhari Singh | YEAR OF INC: 2008 | BSE CODE: 543434 | FV (Rs): 2 | DIV YIELD (%): 0.2 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SUPRIYA LIFESCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.